AmpliPhi Biosciences的封面图片
AmpliPhi Biosciences

AmpliPhi Biosciences

生物技术研究

Marina del Rey，California 1,490 位关注者

AmpliPhi Biosciences and C3J Therapeutics complete merger and formation of Armata Pharmaceuticals

关注

关于我们

Seasoned drug development teams from AmpliPhi Biosciences Corporation and C3J Therapeutics have joined together to form Armata Pharmaceuticals (NYSE American: ARMP) to tackle the global and increasingly serious threat of antimicrobial-resistant bacterial infections. Driven by rigorous and innovative science, Armata is developing high-impact, best-in-class bacteriophage therapeutics with the potential to save millions of lives. Please visit the LinkedIn page at: https://lnkd.in/ga-jvfg and the company website at: www.armatapharma.com

网站
https://www.armatapharma.com
所属行业
生物技术研究
规模
11-50 人
总部
Marina del Rey，California
类型
上市公司
领域
Biotechnology、Infectious Disease、Antibiotic Resistance、Antimicrobial resistance、Phage Therapy、Phage、Bacteriophage和Anti-infectives

地点

  • 主要

    4503 Glencoe Ave

    US，California，Marina del Rey，90292

    获取路线

AmpliPhi Biosciences员工

查看全部员工

相似主页

查看职位

融资

AmpliPhi Biosciences 共 5 轮

上一轮

上市后股权

US$13,000,000.00

在 Crunchbase 上查看更多信息